We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NWFL:NASDAQNorwood Financial Corp. Analysis

Data as of 2026-06-03 - not real-time

$29.36

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Norwood Financial Corp. (NWFL) is trading at $29.36, comfortably above its 200‑day SMA of $28.39 but slightly below the 20‑day ($29.95) and 50‑day ($30.10) averages, indicating a neutral short‑term trend. The stock benefits from a PE ratio of 10.75, well under the industry average of 16.41, and a price‑to‑book of 1.12**, suggesting it is undervalued relative to peers. Momentum indicators are modestly bullish – the MACD line sits above its signal and the histogram is positive – while the RSI at 44 signals no immediate overbought or oversold condition. Dividend investors are attracted by a 4.19% yield with a sustainable payout ratio of 45.8%, supported by solid operating cash flow and a net cash position (cash exceeds debt). Recent insider buying and upbeat analyst price targets around $33.5 add confidence, though the stock’s 30‑day volatility is high at 35.9%. Overall, the combination of attractive valuation, strong dividend profile, and modest bullish technical signals makes NWFL a compelling candidate for investors seeking a blend of income and growth.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price is near established support at $28.68
  • Bullish MACD crossover with increasing volume
  • Neutral RSI and modest volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst target price of $33.5 implies ~14% upside
  • Strong revenue growth (33% YoY) and healthy profit margins
  • Sustainable 4.19% dividend yield

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • DCF fair value of $73.09 suggests significant re‑rating potential
  • Low beta (0.6) indicating defensive characteristics
  • Robust cash position and consistent dividend payments

Key Metrics & Analysis

Financial Health

Revenue Growth33.40%
Profit Margin27.76%
P/E Ratio10.8
ROE10.19%
ROA0.97%
P/B Ratio1.1
Op. Cash Flow$30.9M
Industry P/E16.4

Technical Analysis

TrendNeutral
RSI44.3
Support$28.68
Resistance$31.28
MA 20$29.95
MA 50$30.10
MA 200$28.39
MACDBullish
VolumeIncreasing
Fear & Greed Index92.75

Valuation

Fair Value$73.09
Target Price$33.50
Upside/Downside14.10%
GradeUndervalued
TypeBlend
Dividend Yield4.19%

Risk Assessment

Beta0.60
Volatility35.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.